Browse Related Topics For:

Pharmaceutical Industry

1218
Prescription Drugs
1127
FDA
1100
Patents
835
Pharmaceutical Patents
693
Patent Litigation
584
Generic Drugs
551
Patent Infringement
485
Biosimilars
469
Medical Devices
337
ANDA
303
Healthcare
248
SCOTUS
247
Biotechnology
237
Hatch-Waxman
235
Manufacturers
213
BPCIA
209
Health Care Providers
206
Drug Pricing
199
Life Sciences
196
Biologics
196
Popular
185
EU
164
FTC
162
HHS
162
Off-Label Promotion
159
CMS
155
Pharmacies
149
Medicare
147
Physicians
138
Clinical Trials
137
Affordable Care Act
136
Amgen
134
China
132
Medicaid
128
False Claims Act (FCA)
127
Sandoz
126
Section 340B
125
DOJ
122
FDA Approval
122
Hospitals
122
Intellectual Property Protection
121
Teva Pharmaceuticals
118
Mylan Pharmaceuticals
115
FDCA
112
Patent-in-Suit
109
Patent Trial and Appeal Board
106
Inter Partes Review (IPR) Proceeding
103
First Amendment
100
Sandoz v Amgen
99
Enforcement Actions
99
Preemption
96
Appeals
96
SEC
95
Off-Label Use
92
Compliance
91
Pfizer
90
HRSA
89
Class Action
83
Actavis Inc.
83
OIG
82
Claim Construction
80
UK
79
Labeling
79
USPTO
78
Obviousness
76
Marketing
76
Opioid
74
Failure To Warn
74
Novartis
73
Antitrust Litigation
73
FCPA
72
Trump Administration
71
Corporate Counsel
70
Anti-Kickback Statute
70
Reverse Payment Settlement Agreements
68
Draft Guidance
68
Pay-For-Delay
66
European Medicines Agency (EMA)
66
GlaxoSmithKline
65
Australia
65
Patent-Eligible Subject Matter
63
Personal Jurisdiction
62
FTC v Actavis
61
Sunshine Act
60
Health Insurance
58
Apotex
58
Medical Research
58
Patent Dance
58
Regulatory Standards
57
AbbVie
57
Bribery
56
Advertising
56
Comment Period
56
Orphan Drugs
56
Teva v Sandoz
55
Preliminary Injunctions
55
Reporting Requirements
55
Settlement
55
Warning Labels
54
Civil Monetary Penalty
54
Prior Art
52
AstraZeneca
52
Commercial Marketing
52
Patent Applications
52
Whistleblowers
51
Federal Rules of Civil Procedure
51
Infringement
50
Amarin
50
De Novo Standard of Review
50
Financial Institutions
50
Regulatory Oversight
49
Fraud
49
Free Speech
49
Medicare Part D
49
Merck
48
Canada
48
Clear Error Standard
47
Patent Invalidity
46
21st Century Cures Initiative
46
Bayer
46
Criminal Prosecution
46
Disclosure Requirements
46
Research and Development
45
PHRMA
43
Proposed Legislation
42
Competition
42
Legislative Agendas
42
Multidistrict Litigation
42
Pending Legislation
41
Allergan Inc
41
Cancer
41
Covered Entities
41
Hospira
41
Misbranding
41
Summary Judgment
40
Acquisitions
39
Drug & Alcohol Abuse
39
Johnson & Johnson
39
Mergers
39
Negligence
39
Product Defects
39
Public Health
38
Antitrust Provisions
38
Final Rules
37
America Invents Act
37
Drug Safety
37
Eli Lilly
37
Notice Requirements
37
White Collar Crimes
36
Drug Compounding
36
Healthcare Reform
35
Bristol-Myers Squibb
35
Design Defects
35
Dismissals
35
Hart-Scott-Rodino Act
35
Qui Tam
35
Sherman Act
34
Declaratory Judgments
34
HIPAA
34
Trademarks
33
Healthcare Facilities
33
Kickbacks
33
Securities Fraud
33
Transparency
32
Innovation
32
Janssen Pharmaceuticals
32
Watson Pharmaceuticals
31
Anti-Corruption
31
Causation
31
EPA
31
European Commission
31
Financial Markets
31
Insurance Industry
31
Mass Tort Litigation
31
Motion to Dismiss
31
Product Labels
31
Safe Harbors
31
Substance Abuse
30
Anti-Competitive
30
Commercial Speech
30
Enforcement
30
Expert Testimony
30
Jurisdiction
30
New Guidance
29
DNA
29
Gilead Sciences
29
Healthcare Fraud
29
Insider Trading
29
Proposed Regulation
29
UK Brexit
28
Abbott Laboratories
28
Antitrust Violations
28
False Advertising
28
Genentech
28
GPOs
28
New Legislation
27
Attorney Generals
27
Learned Intermediary
27
Medicare Part B
27
Mental Health
27
NIH
27
Public Comment
27
Standing
26
Banking Sector
26
Corruption
26
Cybersecurity
26
Discovery
26
Imports
25
aBLA
25
Celltrion
25
DaimlerChrysler v Bauman
25
General Jurisdiction
25
Specific Jurisdiction
25
Technology Sector
24
Biologics Price Competition and Innovation Act of 2009
24
Misrepresentation
24
Supply Chain
23
Hazardous Waste
23
Product Hopping
23
Valeant
22
Automotive Industry
22
Biopharmaceutical
22
Birth Defects
22
Damages
22
Disgorgement
22
Ethics
22
FFDCA
22
PLIVA v Mensing
22
Scientific Research
22
Takeda Pharmaceuticals
22
Warning Letters
21
Boehringer
21
Bristol-Myers Squibb Co v Superior Court of California - San Francisco County
21
Class Certification
21
Russia
21
Strict Liability
21
Trans-Pacific Partnership
20
DEA
20
France
20
India
20
Patients
20
Pleading Standards
20
Securities Litigation
20
Social Media
20
Trade Secrets
20
Wrongful Death
19
Audits
19
Caronia
19
Citizen Petitions
19
DSCSA
19
Forum Shopping
19
Hedge Funds
19
Lanham Act
19
Licenses
19
Medical Malpractice
19
Orange Book
19
Pain Management
19
Patent Reform
19
Post-Grant Review
19
Public Health Service Act
19
Regulatory Agenda
18
Antitrust Investigations
18
Chief Compliance Officers
18
Coherus
18
Duty to Warn
18
Final Guidance
18
Mutual Pharmaceuticals v Bartlett
18
Product Exclusivity
18
Professional Conferences
18
RCRA
18
Unfair Competition
17
21st Century Cures Act
17
Congressional Investigations & Hearings
17
Drug Approvals
17
Evidence
17
Intellectual Property Litigation
17
Omnicare
17
On-Sale Bar
17
Personalized Medicine
17
Prescription Drug Coverage
17
Price-Fixing
17
Putative Class Actions
17
Side Effects
17
Stocks
17
UK Competition and Markets Authority (CMA)
17
Wholesale
16
Barack Obama
16
Controlled Substances
16
Exports
16
Federal Contractors
16
GAO
16
Genetic Materials
16
Innovator Liability
16
IP License
16
Italy
16
License Agreements
16
Monopolization
16
Myriad
16
Par Pharmaceutical
16
Penalties
16
Reimbursements
16
Relators
16
REMS
16
Technology
16
Warner Chilcott
16
Yates Memorandum
15
Administrative Procedure Act
15
AMP v Myriad
15
CA Supreme Court
15
Cartels
15
Cephalon
15
Certiorari
15
Data Protection
15
Diagnostic Tests
15
Distributors
15
Japan
15
Joint Venture
15
Open Payments
15
Patent Term Extensions
15
Private Equity
15
Retailers
15
Samsung Bioepis
15
Settlement Agreements
15
Wells Fargo
15
World Health Organization
14
China FDA
14
Competition Authorities
14
Data Breach
14
Dietary Supplements
14
DQSA
14
Drug Distribution
14
Energy Sector
14
Foreign Investment
14
Government Investigations
14
Investigational New Drug Application (IND)
14
Marketing Authorization Application
14
Mayo v. Prometheus
14
Medicare Advantage
14
OMB
14
Physician Medicare Reimbursements
14
Pregnancy
14
Rebates
14
Repeal
14
Securities
14
Telemedicine
14
Trade Agreements
14
Universal Health Services Inc v United States ex rel Escobar
14
Venture Capital
14
Wyeth
13
Amgen v Sandoz
13
CAFA
13
Confidential Information
13
Copyright
13
DOL
13
Due Process
13
Endo Pharmaceuticals
13
Expert Witness
13
Fee-for-Service
13
Fiduciary Duty
13
Inadequate Warning
13
Induced Infringement
13
Injunctive Relief
13
Interchangeability
13
IPO
13
Martin Shkreli
13
Material Misstatements
13
Member State
13
New Regulations
13
Oil & Gas
13
Omnicare v Laborers District Council
13
PHI
13
Product Recalls
13
Professional Misconduct
13
RICO
13
Risk Assessment
13
Risk Management
13
Section 11
13
Social Networks
13
Software
13
Startups
13
Theranos
12
Banks
12
Breach of Contract
12
CDC
12
Chemicals
12
CHIP
12
Co-payments
12
Foreign Corporations
12
Injunctions
12
Medtronic
12
Misleading Statements
12
OFAC
12
Public Meetings
12
Publicly-Traded Companies
12
Punitive Damages
12
Remand
12
Sanofi
12
Sanofi-Aventis
12
Stark Law
12
Teaching Hospitals
12
Ukraine
12
Unfair or Deceptive Trade Practices
12
User Fees
11
3D Printing
11
Adverse Events
11
Brazil
11
Breach of Warranty
11
Controlled Substances Act
11
Data Collection
11
Exclusivity
11
Export Controls
11
Fraudulent Joinder
11
Generic
11
Genzyme
11
Google
11
Health Information Technologies
11
Human Genes
11
Investors
11
Long Term Care Facilities
11
Manufacturing Defects
11
MCOs
11
Mexico
11
Nexium
11
Otsuka Pharmaceutical
11
Patient Safety
11
Payment Records
11
Petition for Writ of Certiorari
11
Presidential Elections
11
Public Disclosure
11
Registration Requirement
11
RMBS
11
Securities Act of 1933
11
Securities Exchange Act
11
State and Local Government
11
Subject Matter Jurisdiction
11
Tax Credits
11
Telecommunications
11
Vaccinations
11
Young Lawyers
10
Agricultural Sector
10
Anti-Monopoly
10
CFDA
10
Clinical Laboratories
10
Corporate Culture
10
Defense Strategies
10
Department of Health
10
Durable Medical Equipment
10
En Banc Review
10
Federal Budget
10
Federal Funding
10
Financial Conduct Authority (FCA)
10
First-to-File
10
Food Manufacturers
10
Fourteenth Amendment
10
Fraud and Abuse
10
Genetic Testing
10
Hackers
10
Informed Consent
10
Inspections
10
Inventions
10
Joinder
10
Jury Instructions
10
Managed Care Contracts
10
Materiality
10
Medical Supplies
10
Merger Agreements
10
Ministry of Health
10
Negligent Misrepresentation
10
Nurses
10
Nursing Homes
10
Omnibus Guidance
10
OxyContin
10
Patent Term Adjustment
10
Physician Payments
10
Referendums
10
Registration Statement
10
Reverse Payments
10
Safety Standards
10
Sanctions
10
Scienter
10
Stem cells
10
Zoloft
9
ACOs
9
Antitrust Division
9
Arbitration
9
Biogen Idec
9
Brand
9
CETA
9
CLS Bank v Alice Corp
9
Conflicts of Interest
9
Continuing Medical Education
9
Corporate Integrity Agreement
9
Cross-Border Transactions
9
Deferred Prosecution Agreements
9
Digital Health
9
EEA
9
Federal Pilot Programs
9
Fiduciary Rule
9
Fines
9
Germany
9
Good Faith
9
Healthcare Costs
9
Illegal Drugs
9
Investment
9
Ireland
9
Legislative Committees
9
Meals-Gifts-and Entertainment Rules
9
Medicaid Expansion
9
Medical Marijuana
9
Multinationals
9
Obama Administration
9
OCR
9
OPDP
9
Patient Assistance Programs
9
Private Right of Action
9
Public Safety
9
RanBaxy
9
Roxane Laboratories
9
Rule-of-Reason Analysis
9
Rulemaking Process
9
Samsung
9
Securities Violations
9
Shareholder Litigation
9
Standard of Review
9
Statute of Limitations
9
Strategic Enforcement Plan
9
Toxic Exposure
9
Vacated
9
Value-Based Purchasing
9
Websites
8
Amgen v Hospira
8
Aviation Industry
8
Big Data
8
BRCA
8
Burden of Proof
8
CFPB
8
CGMP
8
Cosmetics
8
Cost-Sharing
8
Due Diligence
8
E-Commerce
8
Emerging Growth Companies
8
Employee Benefits
8
Environmental Policies
8
Executive Orders
8
False Statements
8
FD&C Act
8
FINRA
8
FOIA
8
Guidance Update
8
Hiring & Firing
8
Interpretive Rule
8
Inventors
8
IRS
8
Jury Verdicts
8
License Applications
8
Litigation Strategies
8
MedPAC
8
Mensing
8
Monsanto
8
Native American Issues
8
Noninfringement
8
Patent Prosecution
8
Permanent Injunctions
8
Personal Care Products
8
PHSA
8
Public Hearing
8
Public Offerings
8
Recordkeeping Requirements
8
Regulatory Agencies
8
Reversal
8
Royalties
8
Safe Drug Disposal
8
Shareholders
8
Sovereign Immunity
8
State of Incorporation
8
TRIPS Agreement
8
USDA
8
Wage and Hour
8
Written Descriptions
8
WTO
7
Abuse of Dominance
7
Administrative Proceedings
7
Africa
7
AIDS
7
Allergan v Sandoz
7
Article III
7
Asia
7
Australian Medical Association
7
Australian Patent Office
7
Bank Accounts
7
Black Box Warnings
7
Bonds
7
Breach of Duty
7
C-Suite Executives
7
Capital Raising
7
Choice-of-Law
7
Compensatory Damages
7
Criminal Conspiracy
7
CVS
7
Databases
7
Daubert Standards
7
Discount Pricing
7
Dodd-Frank
7
Economic Development
7
Facebook
7
Fair Work Commission
7
FCC
7
Federal Jurisdiction
7
Federal Register
7
Federal Rule 12(b)(6)
7
Food and Drug Administration Amendments Act (FDAAA)
7
Food Labeling
7
Forest Laboratories
7
Funding
7
Goldman Sachs
7
Hoffman LaRoche
7
Home Health Care
7
Hospital Mergers
7
Indictments
7
Innovation Act
7
Internal Controls
7
International Harmonization
7
Inversion
7
ITC
7
Jazz Pharmaceuticals
7
JPMorgan Chase
7
Licensing Rules
7
Limelight v Akamai
7
Medicaid Reimbursements
7
Medical Reimbursement
7
Medicines and Healthcare Products Regulatory Agency (MHRA)
7
Mobile Apps
7
Myriad-Mayo
7
Negotiations
7
New Zealand
7
OECD
7
Outsourcing
7
Pleadings
7
Premerger Notifications
7
Price Gouging
7
Radiopharmaceuticals
7
Regulatory Reform
7
Secretary of HHS
7
Section 101
7
Section 337
7
Skilled Nursing Facility
7
Subpoenas
7
Suppliers
7
Tariffs
7
TCPA
7
Telehealth
7
The Clayton Act
7
Third-Party
7
Trademark Infringement
7
Twombly/Iqbal Pleading Standard
7
US v Salman
7
Walgreens
7
Yahoo!
6
ALJ
6
Amgen v Apotex
6
Anti-Bribery
6
Anticompetitive Behavior
6
Applications
6
Attorney-Client Privilege
6
Bayh-Dole Act
6
BIS
6
CEOs
6
Chevron Deference
6
Commercial Bankruptcy
6
Compulsory Licenses
6
Conspiracies
6
Consumer Fraud
6
Corporate Misconduct
6
Corporate Taxes
6
Covered Recipients
6
Cross-Border
6
Cross-Selling
6
Cyber Attacks
6
Data Security
6
Data-Sharing
6
Daubert Ruling
6
Declaratory Relief
6
Deutsche Bank
6
Diagnostic Method
6
Digital Currency
6
Direct Infringement
6
Dirks v SEC
6
Disclosure
6
Diversity Jurisdiction
6
Economic Sanctions
6
Exclusive Dealing Agreements
6
False Implied Certification Theory
6
FDARA
6
Foreign Manufacturers
6
Foreign Official
6
Forex
6
Forum
6
FTC Act
6
General Motors
6
Guilty Pleas
6
Health Canada
6
Health Insurance Exchanges
6
Illegal Tipping
6
Information Technology
6
Initial Public Offerings
6
Interest Rate Adjustments
6
Internet
6
Iran
6
JAMA
6
Janssen v Celltrion
6
Lipitor
6
Medical Records
6
Merger Controls
6
Method Claims
6
Money Laundering
6
Mortgages
6
Motion for Summary Judgment
6
NAFTA
6
Online Advertisements
6
OTC
6
Over-the-Counter Sales
6
Partnerships
6
Patent Exhaustion
6
Patent Trolls
6
Patient Privacy Rights
6
PDUFA
6
Personal Benefit
6
Pharmaceutical Reverse Distributors
6
Pharmacist
6
Proposed Amendments
6
Provider Payments
6
Public Health Insurance Marketplace
6
Real Party in Interest
6
Retaliation
6
Risk Mitigation
6
SDN List
6
SFDA
6
Shire Development v Watson
6
Small Business
6
South Africa
6
South Korea
6
Spain
6
Standard Essential Patents
6
Statement of Opinion
6
Swiss Style Claims
6
Tax Reform
6
Toxic Chemicals
6
Trademark Registration
6
Transportation Industry
6
US v Newman
6
USTR
5
510(k) RTA
5
Abuse of Process
5
Admissible Evidence
5
Advisory Opinions
5
Alibaba
5
American Medical Association
5
Amicus Briefs
5
Apple
5
Arbitration Agreements
5
Attorney's Fees
5
Aurobindo Pharmaceuticals
5
Australian Competition and Consumer Commission
5
Best Practices
5
Board of Directors
5
Bodily Injury
5
CAFC
5
Celebrity Endorsements
5
Cipro
5
Classen Immunotherapies
5
Competition Act
5
Construction Industry
5
Consumer Lenders
5
Counterfeit Drugs
5
Criminal Investigations
5
Data Privacy
5
Department of Veterans Affairs
5
Direct to Consumer Sales
5
Dispute Resolution
5
Divestiture
5
Divided Infringement
5
Doctrine of Equivalents
5
Domestic Violence
5
Dormant Commerce Clause
5
Elder Abuse
5
Employer Group Health Plans
5
Enablement Inquiries
5
Excessive Pricing
5
Fast Track Process
5
FBI
5
FDA Warning Letters
5
FDASIA
5
Federal Reserve
5
Fifth Amendment
5
Food Safety
5
Forum Selection
5
Free Trade Agreements
5
Fresenius
5
General Electric
5
Good Clinical Practices
5
Hazardous Substances
5
HCEI
5
HITECH
5
HIV
5
Hospice
5
Interest Rates
5
International Arbitration
5
Interstate Commerce
5
Investment Management
5
IRB
5
Judicial Review
5
Kaiser Permanente
5
Libor
5
Likelihood of Confusion
5
Local Ordinance
5
Manufacturing Facilities
5
Marijuana
5
MOFCOM
5
Mootness
5
Morgan Stanley
5
Motion To Stay
5
Nanotechnology
5
NDRC
5
No-AG Agreement
5
Online Marketplace Lending
5
Outpatient Prospective Payment System (OPPS)
5
Overpayment
5
Pain Management Clinics
5
PATENT Act
5
Personally Identifiable Information
5
Pharmaceutical Distribution
5
Physician Gift-Ban Law
5
PMNOC Regulations
5
Pre-Merger Filing Requirements
5
Privacy Laws
5
Proposed Rules
5
Proximate Cause
5
PSLRA
5
R&D
5
Regeneron
5
Remedies
5
Removal
5
Retail Market
5
Retirement Plan
5
Section 10(b)
5
Sharing Economy
5
Software Developers
5
Solicitor General
5
Solid Waste
5
Subsidies
5
Sudan
5
Supplementary Protection Certificate
5
Surveys
5
Takeover Bids
5
The Common Rule
5
Trade Agreements Act
5
Trade Relations
5
Trademark Trial and Appeal Board
5
Training
5
Tribal Governments
5
Twitter
5
UK Bribery Act
5
Unions
5
Universities
5
Utility Patents
5
Value-Based Care
5
Vendors
5
Venue
5
Verification Requirements
5
Veterinary Products
5
Volkswagen
5
Waivers
5
Warranties
5
Webinars
4
23andMe
4
Acquittals
4
Actos
4
Administrative Authority
4
Advisory Committee
4
Aerospace
4
Alzheimer's
4
Amazon Marketplace
4
Amended Legislation
4
Amended Regulation
4
Anti-SLAPP
4
Antibiotics
4
Antitrust Conspiracies
4
Antitrust Injuries
4
Applicable Manufacturers
4
Ascertainable Class
4
Ballot Measures
4
Barclays
4
Bitcoin
4
Calculation of Damages
4
Cardinal Health
4
Center for Drug Evaluation and Research (CDER)
4
Certificate of Need
4
Charitable Organizations
4
Climate Change
4
CMMI
4
Code of Conduct
4
Commercial General Liability Policies
4
Confidentiality Agreements
4
Congressional Committees
4
Consent Order
4
Contraceptives
4
Cooperation
4
Corporate Governance
4
Counterclaims
4
Counterfeiting
4
Criminal Penalties
4
Cuba
4
Daiichi Sankyo
4
Dairy Farmers
4
Department of Transportation (DOT)
4
Deregulation
4
Derivative Suit
4
Direct Purchasers
4
DMEPOS
4
Double Patent
4
Duty of Care
4
Duty to Deal
4
EAR
4
Earnings Reports
4
EHR
4
Elan Pharmaceuticals
4
Emerging Markets
4
Employment Contract
4
ERISA
4
EU Single Market
4
EU-US Privacy Shield
4
European Court of Justice (ECJ)
4
Excessive Fines Clause
4
Exemptions
4
Failure To Disclose
4
Failure To State A Claim
4
Federal Health Care Programs (FHCP)
4
Financial Crisis
4
Food Recalls
4
Foreign Currency
4
Forum Non Conveniens
4
FRAND
4
French Competition Authority
4
GDUFA
4
Genetic Markers
4
Global Marketplace
4
Governor Brown
4
Governor Christie
4
Hepatitis C
4
Human Rights
4
Implied Preemption
4
Individual Accountability
4
Individual Mandate
4
Inducements
4
Infectious Diseases
4
Interlocutory Appeals
4
Interlocutory Injunctions
4
InterMune
4
Investment Adviser
4
Irreparable Harm
4
Job Creation
4
Kim Kardashian
4
Kimble v Marvel Enterprises
4
Laboratory Developed Tests
4
Market Manipulation
4
Martoma
4
Material Nonpublic Information
4
Medicare Access and CHIP Reauthorization (MACRA)
4
Mental Health Parity Rule
4
Microsoft
4
Middle East
4
Minimum Contacts
4
Mining
4
Misleading Impressions
4
Motion To Strike
4
National Cancer Moonshot
4
Non-Prosecution Agreements
4
Non-Public Information
4
Nutritional Supplements
4
Outpatient Services
4
Patent Portfolios
4
Patented Medicines
4
Patient Access
4
Pediatrics
4
Pension Funds
4
Pensions
4
Personal Liability
4
Physician Fee Schedule
4
Policies and Procedures
4
Prejudgment Interest
4
Premarket Approval Applications
4
Premiums
4
Prescribing Authority
4
Principal Place of Business
4
Prior Express Consent
4
Product Packaging
4
Public Officials
4
Puerto Rico
4
Quality Control Plan